Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$NWBO pic.twitter.com/6vg1pge5bg
— 🇩🇰 The Danish Dude 🇩🇰 (@FlemmingBruce) March 31, 2023
It’s coming. And as I have said many times, sooner than most think $NWBO https://t.co/36T53Xgxbr
— Fireman02360 (@fyre02532) March 30, 2023
shine the bright light on watch the roaches run
It may be because they have the biggest target on their back. we will see
1)My friend told me via email the decision by Posner to amend the compliant could be for many reasons, such as as to include additional claims/parties, correct facts, add additional parties to the suit, or clear up false claims
2) He said it there is something in the MTD letter by Ds that made Posner do this. Its not detrimental to the original claim at all, as defendants present responses to the Court for MTD, additional facts and details change the approach and scope.His words: "She is being Prudent"
Yes and this could also include expanding the date range to include more recent dates if spoofing of the $NWBO stock price has continued since the original filing.
Michael Bigger
@biggercapital
$CROX was the big upcoming story in shoes, $PLUG was the big upcoming story in industrial energy, $NWBO is the big upcoming biotech story now. MIA approval means the company can’t be killed. GOING ALL IN ON ALL SOLID TUMORS
st case scenario, with only shipping 100/month we're at $2 right now. Simple math. $nwbo
4
annie post
@apwriter
·
9m
Looks like those naked #s were real. W MAA in 30 days or so, zero chance a squeeze is avoided. $nwbo
52
annie post
@apwriter
·
21m
We're at $2 now w a mere 100 pts. Sure. Piss of the judge. He can do math too. $nwbo
jt. it was directed to ATLnsider
lol lol lol lol lol lol lol lol lol. haaaaaa that's funny. now see ya
that's what you were looking for last time. you should be happy. sell now
sounds like they are ready to be in todays congress
I guess if you are ok with saying $11,600 is making it. 58k shares @ .20. Then that's fine. To each their own. Good luck. Would have done much better if you picked up 250k shares at .17 and dumped at $2.20. That was a fun day.
The long game is still in play. Hold this time grip. Maybe that 58k shares will feel much better a year from now. GL
Philippe Pire
Chief Financial Officer at Advent Bioservices
New York, New York, United States
242 followers 236 connections
Join to view profile
Advent Bioservices ltd
Advent Bioservices ltd
Université Paris Dauphine
Université Paris Dauphine
About
Results-driven CEO/CFO. 25+ years' business/operational finance experience. Develop global financial strategy, raise capital, manage investments, create sustainable value, implement efficiencies and internal controls, M&A integration, problem solve and IR. M&A experience includes acquisitions and divestitures.
Armed with quantitative and analytical skills, I am well-equipped to address pressing challenges and capitalize on opportunities. Managed teams of 100+ in economically volatile environments, Accustomed to solving multiple issues creatively and under extreme pressure. I actively anticipate when to implement changes in direction, prioritizing and delegating tasks, and motivating others to achieve targeted objectives in a timely and efficient manner.
Key strengths include:
FINANCE
• Lead continuous evaluation of short/long-term strategic financial objectives
• Optimize management of capital sources and their uses
• M&A
• Investor Relations (manage relationships with financial markets; lenders; investors; etc.)
• Timely, accurate analysis of budgets, financial trends and forecasts
• Audit, budget and financial forecasting
• Strategically enhance financial performance and business opportunities
• Seek and negotiate capital raising transactions
• Ensure effective internal controls, compliance with GAAP and applicable regs governing financial and tax reporting
MANAGEMENT/LEADERSHIP
• Develop strategic plan
• Hire, motivate and direct teams of men and women
• Create new organizations and deploy work force
BUSINESS DEVELOPMENT
• Design strategies to achieve, sustain and recapture market leadership and growth
• Expand geographic footprint/wholesale and retail franchise operations in appropriate global markets
• Launch new product lines
• Increase manufacturing capabilities
• Improve brand name recognition
COMMUNICATION
• Liaise with media in connection with PR strategy
Activity
Proud to work alongside Laura Connor Smith, CVA, CFE and Rebecca Vélez at Credibility.
Proud to work alongside Laura Connor Smith, CVA, CFE and Rebecca Vélez at Credibility.
Liked by Philippe Pire
Officialisée en 1977, le 8 mars est une journée internationale d’action, de sensibilisation et de mobilisation dédiée à la lutte pour les droits des…
Officialisée en 1977, le 8 mars est une journée internationale d’action, de sensibilisation et de mobilisation dédiée à la lutte pour les droits des…
Liked by Philippe Pire
Immensely proud of Plume Design, Inc’s efforts to educate refugee children and to lead our sustainability programs. Thank you to those who’ve given…
Immensely proud of Plume Design, Inc’s efforts to educate refugee children and to lead our sustainability programs. Thank you to those who’ve given…
Liked by Philippe Pire
Join now to see all activity
Experience
Advent Bioservices ltd Graphic
Chief Financial Officer
Advent Bioservices ltd
May 2018 - Present4 years 11 months
London, England, United Kingdom
As Chief Financial Officer of Advent, I am responsible for all financial aspects of the business. Further, I develop and implement strategic initiatives and use financial metrics and tools to drive innovation. My day-today responsabilities also include risk managment and the growth of our operations and expansion of our services into new sectors of the industry.
Cross-Border Consultants, LLC Graphic
Managing Director
Cross-Border Consultants, LLC
2009 - Present14 years
New York; Paris
Provide financial, strategic, management and operational advisory services to public and private companies in a wide range of industries.
Cognate BioServices Graphic
Chief Financial Officer
Cognate BioServices
Feb 2015 - Jun 20183 years 5 months
Hanover, MD
As a member of the executive management team, I reported to the Chief Executive Officer and assumed a strategic role in the overall management of the company. On a day-to-day basis, I had primary responsibility for planning, implementing, managing and controlling all of the company's finance-related activities, including leading the company's management-led buyout in 2018.
Southern California Veterinary Imaging Graphic
Chief Financial Officer; Chief Strategy Officer
Southern California Veterinary Imaging
Feb 2015 - May 20183 years 4 months
Greater Los Angeles Area
I am a member of the executive management team. In this role, I report to and advise the Chief Executive Officer and assume a strategic role in the overall management of the company and its implementation of initiatives to build the business and drive growth, including through M&A. I have primary responsibility for all aspects of finance-related activity.
Veterinary Cancer Group Graphic
Chief Financial Officer
Veterinary Cancer Group
Jun 2013 - May 20185 years
Greater Los Angeles Area
As Veterinary Cancer Group's (VCG) Chief Financial Officer, I developed and implemented business/finance strategies to achieve targeted levels of EBITDA. Negotiated sale to private equity fund. Post-sale, I continue to work as a strategic advisor, focused on continually and directly driving the growth and further development of the business. Also responsible for finance, accounting, financial forecasting, and deal analysis.
Oberthur Fiduciaire Graphic
Director, Business Development, Africa
Oberthur Fiduciaire
2012 - 20131 year
Paris
Advised African ministries on strategies to prevent and eliminate counterfeiting of secure documents, including passports, birth and death certificates, currency and other financial and fiscal instruments.
M3 Ventures, LLC Graphic
CEO
M3 Ventures, LLC
2009 - 20112 years
New York / Paris
- Responsible for development and execution of investment strategy
Opus Trading Graphic
Equity Trader
Opus Trading
2008 - 20091 year
New York USA
- Responsible for trading equity securities
RBC Graphic
Equity Trader
RBC
2007 - 20081 year
New York usa
- Responsible for trading equity securities
VPL LLC Graphic
CEO and CFO
VPL LLC
Dec 1996 - Dec 200711 years 1 month
Greater New York City Area
• Prior to negotiating sale of the business, performed all functions related to design and manufacturing of women’s private-label merchandise targeted to a young, fashion-conscious, mass-market (Express, Limited, Bebe and Saks Fifth Avenue).
• Developed and implemented business operational, financial, and marketing strategies.
• Directed and supervised all domestic and overseas manufacturing.
• Performed all accounting and reporting functions including quality assurance.
Vertigo NYC Graphic
Vice President and CFO
Vertigo NYC
Mar 1989 - Dec 200718 years 10 months
Greater New York City Area
• Structured all aspects of business, including creation and implementation of strategies to expand wholesale operations and franchise program prior to negotiating all aspects of the sale of the business.
• Increased points of sale and generally improved brand equity ($50M).
• Directed all financial plans and accounting practices, implemented cost controls, and prepared internal financial and statistical reports.
• Directed wholesale and retail purchasing including marketing…
Show more
Education
Université Paris Dauphine Graphic
Université Paris Dauphine
Master of Business Administration (MBA)Finance
1983 - 1984
Universite de Paris II Graphic
Universite de Paris II
Master's degreeEconomics and Finance
1978 - 1982
Licenses & Certifications
Series 7 (expired) Graphic
Series 7 (expired)
-
Languages
English
Native or bilingual proficiency
French
Native or bilingual proficiency
More activity by Philippe
Portes là haut??, avec fierté et le plus longtemps possible ?? Tu le mérites , et c est ce que je te souhaite #burgerking Alexandre Simon
Portes là haut??, avec fierté et le plus longtemps possible ?? Tu le mérites , et c est ce que je te souhaite #burgerking Alexandre Simon
Liked by Philippe Pire
Congratulations to Selena one of our Senior GMP Production Scientists who has been awarded one of the ISCT Europe Master Programme Scholarships…
Congratulations to Selena one of our Senior GMP Production Scientists who has been awarded one of the ISCT Europe Master Programme Scholarships…
Liked by Philippe Pire
https://lnkd.in/eTsmZzdf #ATAC #apprenticeships
https://lnkd.in/eTsmZzdf #ATAC #apprenticeships
Liked by Philippe Pire
Our latest #PlumeIQ outlines the main trends that have shaped the smart home market in 2022, from the rise of data consumption in US households to…
Our latest #PlumeIQ outlines the main trends that have shaped the smart home market in 2022, from the rise of data consumption in US households to…
Liked by Philippe Pire
What was an amazing seminar we had with the ENGIE’s Digital and IT 100 top leaders ! They were all at the rendez-vous. Driving Digital…
What was an amazing seminar we had with the ENGIE’s Digital and IT 100 top leaders ! They were all at the rendez-vous. Driving Digital…
Liked by Philippe Pire
The Autolomous team wants to welcome you in the new year! May 2023 bring exciting developments in the cell and gene therapy space - let’s make it…
The Autolomous team wants to welcome you in the new year! May 2023 bring exciting developments in the cell and gene therapy space - let’s make it…
Liked by Philippe Pire
As we come to the end of 2022, I take this opportunity to thank our wonderful staff for the amazing amount of work put in this year as we continue to…
As we come to the end of 2022, I take this opportunity to thank our wonderful staff for the amazing amount of work put in this year as we continue to…
Liked by Philippe Pire
????Great work team ?? Best service provider solution & best in-home wifi Solution!!! It goes to show service providers and consumers are looking…
????Great work team ?? Best service provider solution & best in-home wifi Solution!!! It goes to show service providers and consumers are looking…
Liked by Philippe Pire
We had a great time showcasing what Advent Bioservices have to offer at #BioprocessUK - it was lovely to meet so many interesting people and…
We had a great time showcasing what Advent Bioservices have to offer at #BioprocessUK - it was lovely to meet so many interesting people and…
Liked by Philippe Pire
Looking forward to attending the BIA meeting in Edinburgh next week. Come and visit the Advent Bioservices stand to find out about our manufacturing,…
Looking forward to attending the BIA meeting in Edinburgh next week. Come and visit the Advent Bioservices stand to find out about our manufacturing,…
Liked by Philippe Pire
Perfect harmony. That's life with Plume Design, Inc's Adaptive WIFI. Smart technology that understands your needs. Be wowed by my colleagues Fahri…
Perfect harmony. That's life with Plume Design, Inc's Adaptive WIFI. Smart technology that understands your needs. Be wowed by my colleagues Fahri…
Liked by Philippe Pire
View Philippe’s full profile
See who you know in common
Get introduced
Contact Philippe directly
Join to view full profile
People also viewed
Donna Sleight
Office Manager at Advent Bioservices
This means #DCVAX can be exported globally… $NWBO #CANCER #GBM #DUMBMEDIA
— Michael Bigger (@biggercapital) March 20, 2023
MHRA approval next. $NWBO
— Michael Bigger (@biggercapital) March 20, 2023
This means #DCVAX can be exported globally… $NWBO #CANCER #GBM #DUMBMEDIA
— Michael Bigger (@biggercapital) March 20, 2023
I agree
For NovoCure Ltd (NASDAQ:NVCR), JP Morgan downgraded the previous rating of Neutral to Underweight. NovoCure earned $0.36 in the fourth quarter, compared to $0.25 in the year-ago quarter. At the moment, the stock has a 52-week-high of $120.03 and a 52-week-low of $56.39. NovoCure closed at $64.43 at the end of the last trading period.
Can’t deny #dcvax benefits accruing to @ThomasOwenMcCa1 and compassionate cases #1 and #2 and many more. Show me the alternatives long term survivors? Self-Evident Benefits https://t.co/xL733Q4kDW $NWBO
— Michael Bigger (@biggercapital) March 18, 2023
High rates of cancer among military pilots have been discovered by a Pentagon study.
And for the first time, it's been shown that ground crews that fuel, maintain and launch those aircraft are getting sick as well.
The Pentagon released the study in early February, the Associated Press reported.
#89 Patrick Soon-Shiong
Net Worth: $8.9 B
Age: 69
State: California
Source: Pharmaceuticals
Philanthropy Score: 1
Medical doctor Patrick Soon-Shiong invented the cancer drug Abraxane. It became a blockbuster thanks to its efficacy against pancreatic cancer. He sold his drug companies Abraxis in 2010 and American Pharmaceutical Partners in 2008 for a combined $9.1 billion.